FDA Approved: ORBACTIV — Original Application (Melinta Therapeutics, LLC)

View source ↗

Summary

FDA approved ORBACTIV (oritavancin) in its original NDA for the treatment of acute bacterial skin and skin structure infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• Orbactiv (oritavancin)

Snippet

ORIG AP for ORBACTIV (ORITAVANCIN)